Liquid Biopsy Market Global Industry Analysis and Forecast (2024-2032)
The Global Liquid Biopsy Market size is expected to grow from USD 1.91 billion in 2023 to USD 10.19 billion by 2032, at a CAGR of 20.42% during the forecast period (2024-2032).
A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample. In 1994, scientists advanced to the point where they could detect specific mutations in ctDNA. Dennis Lo discovered fetal cfDNA in the blood in 1997, and Veridex released the first commercially available liquid biopsy assay, the CELL SEARCH CTC test, in 2000